Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Completed · Phase 1
Conditions studied: Leukemia, Lymphoma
In brief
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining biological therapy with chemotherapy may kill more cancer cells. PURPOSE: Phase I trial to study the effectiveness of biological therapy after chemotherapy in treating patients who have relapsed or refractory non-Hodgkin's lymphoma.
Key facts
- Study ID
- NCT00012207
- Run by
- Fred Hutchinson Cancer Center
- People needed
- 12
- Starts
- 2000-09-01
- Expected to finish
- 2010-07-01
- Last updated by the study team
- 2010-08-24
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope Comprehensive Cancer Center — Duarte, California, United States
- Fred Hutchinson Cancer Research Center — Seattle, Washington, United States
- University of Washington School of Medicine — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.